Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related LJPC
The Street Sweeper Moved The Market On La Jolla, But How's Its Overall Success Rate?
Street Sweeper On La Jolla Pharma: 'Lost Opportunity, Insider Questions Should Chop Valuation By Well Over Half'
Related DRII
Benzinga's Top Initiations
Diamond Resorts International Commences Public Offering of 4.833M Shares
Diamond Resorts International's (DRII) CEO David Palmer on Q2 2015 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

DateFirmActionFromTo
Apr 2015OppenheimerInitiates Coverage onOutperform
Mar 2015Chardan CapitalReinstatesBuy
Aug 2014JefferiesInitiates Coverage onBuy

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (LJPC + DRII)

Get Benzinga's Newsletters